Treatment of osteonecrosis of the femoral head with hBMP-2-gene-modified tissue-engineered bone in goats

Journal of Bone and Joint Surgery - Series B

Volumn 89, Issue 1, 2007, Pages 127-132

  Tang, Ting Ting ^a   Lu, B ^a   Yue, B ^a   Xie, X H ^a   Xie, Y Z ^a   Dai, K R ^a   Lu, J X ^b   Lou, J R ^c  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b UNIVERSITÉ DU LITTORAL CÔTE D OPALE   (France)

^c SHANGHAI INSTITUTE OF BIOLOGICAL PRODUCTS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; BONE MORPHOGENETIC PROTEIN 2; CALCIUM PHOSPHATE; LIQUID NITROGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY LIGATION; ARTICLE; BIOMECHANICS; BONE DENSITY; BONE NECROSIS; BONE REMODELING; CELL BASED GENE THERAPY; CELL CULTURE; COMPRESSIVE STRENGTH; CONTROLLED STUDY; DNA MODIFICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMUR HEAD; GENE TRANSFER; GENETIC TRANSDUCTION; GOAT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOPATHOLOGY; IN VIVO STUDY; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TISSUE ENGINEERING; TISSUE REPAIR; VIRAL GENE THERAPY; YOUNG MODULUS;

ANIMALS; BIOMECHANICS; BONE MARROW; BONE MORPHOGENETIC PROTEINS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMUR HEAD; FEMUR HEAD NECROSIS; GENE THERAPY; GOATS; TISSUE ENGINEERING; TRANSFORMING GROWTH FACTOR BETA;

EID: 33846881606     PISSN: 0301620X     EISSN: None     Source Type: Journal    
DOI: 10.1302/0301-620X.89B1.18350     Document Type: Article

References (30)

1. Aaron RK. Osteonecrosis: etiology. pathophysiology, and diagnosis. In: Callaghan JJ, Rosenberg AG, Rubash HE, eds. The adult hip. Vol. 1. Philadelphia: Raven Press, 1998:451.
2. Kiaer T, Pedersen NW, Kristensen KD, Starklint H. Intra-osseous pressure and oxygen tension in avascular necrosis and osteoarthritis of the hip. J Bone Joint Surg [Br] 1990:72-B:1023-30.
3. Lieberman JR, Berry DJ, Mont MA, et al. Osteonecrosis of the hip: management in the 21st century. Instr Course Lect 2003;52:337-55.
4. Mont MA, Jones LC, Einhorn TA, Hungerford US, Reddi A. Osteonecrosis of the femoral head: potential treatment with growth and differentiation factors. Clin Orthop 1998;355 (Suppl):314-35.
5. Yoon TR, Song EK Rowe SM, Park CH. Failure after core decompression in osteonecrosis of the femoral head. Int Orthop 2001;24:316-18.
6. Garino JP, Steinberg ME. Total hip arthroplasty in patients with avascular necrosis of the femoral head: a 2- to 10-year follow-up. Clin Orthop 1997;334:108-15.
7. Katz RL, Bourne RB, Rorabeck CH, McGee H. Total hip arthroplasty in patients with avascular necrosis of the hip: follow-up observations on cementless and cemented operations. Clin Orthop 1992;281:145-51.
8. Sun W, Li Z, Shi Z, et al. Effect of non-hydroxyapatite collagen bone and marrow mesenchymal stem cell on treatment of rabbit osteonecrosis of the femoral head defect. Chinese J Reparative Reconstruc Surg 2005;19:203-6.
9. Gangji V, Hauzeur JP, Schoutens A, et al. Abnormalities in the replicative capacity of osteoblastic cells in the proximal femur of patients with osteonecrosis of the femoral head. J Rheumatol 2003;30:348-51.
10. Hernigou P, Beaujean F, Lambotte JC. Decrease in the mesenchymal stem-cell pool in the proximal femur in corticosteroid-induced osteonecrosis. J Bone Joint Surg [Br] 1999;81-B:349-55.
11. Gangji V, Hauzeur JP, Matos C, et al. Treatment of osteonecrosis of the femoral head with implantation of autologous bone-marrow cells: a pilot study. J Bone Joint Surg [Am] 2004;86-A:1153-60.
12. Hernigou P, Beaujean F. Treatment of osteonecrosis with autologous bone marrow grafting. Clin Orthop 2002;405:14-23.
13. Reddi AH. Bone morphogenetic proteins: from basic science to clinical applications. J Bone Joint Surg [Am]2001;83-A (Suppl):1-6.
14. Lieberman JR, Conduah A, Urist MR. Treatment of osteonecrosis of the femoral head with core decompression and human morphogenetic protein. Clin Orthop 2004;429:139-45.
15. Mont MA. Jones LC, Elias JJ, et al. Strut-autografting with and without osteogenic protein-1: a preliminary study of a canine femoral head defect model. J Bone Joint Surg [Am]2001;83-A:1013-22.
16. Simank HG, Manggold J, Sebald W, et al. Bone morphogenetic protein-2 and growth and differentiation factor-5 enhance the healing of necrotic bone in a sheep model. Growth Factors 2001;19:247-57.
17. Dai KR, Xu XL, Tang TT, et al. Repairing of goat tibial bone defects with BMP-2 gene-modified tissue-engineered bone. Calcif Tissue Int 2005;77:55-61.
18. Lieberman JR, Daluiski A, Stevenson S, et al. The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats. J Bone Joint Surg [Am] 1999;81-A:905-17.
19. Peterson B, Zhang J, Iglesias R, et al. Healing of critically sized femoral defects, using genetically modified mesenchymal stem cells from human adipose tissue. Tissue Eng 2005;11:120-9.
20. Lu JX, Gallur A, Flautre B, et al. Comparative study of tissue reactions to calcium phosphate ceramics among cancellous, cortical, and medullar bone sites in rabbits. J Biomed Mater Res 1998;42:357-67.
21. Lou J, Xu F, Merkel K, Manske P. Gene therapy: adenovirus-mediated human bone morphogenetic protein-2 gene transfer induces mesenchymal progenitor cell proliferation and differentiation in vitro and bone formation in vivo. J Orthop Res 1999;17:43-50.
22. Shanghai Science and Technology Committee. appealσtcsm.gov.cn (date last accessed 25 October 2006).
23. Conzemius MG, Brown TD, Zhang Y, Robinson RA. A new animal model of femoral head osteonecrosis: one that progresses to human-like mechanical failure. J Orthop Res 2002;20:303-9.
24. Noshi T, Yoshikawa T, Ikeuchi M, et al. Enhancement of the in vivo osteogenic potential of marrow/hydroxyapatite composites by bovine bone morphogenetic protein. J Biomed Mater Res 2000;52:621-30.
25. Huiskes R, Vam Rietbergen B. Biomechanics of bone. In: Mow VC, Huiskes R, eds. basic orthopedic biomechanics & mechano-biology. Philadelphia etc: Lippincott, Williams & Wilkins, 2003:20.
26. Newton B, Crawford CJ, Powers DL, Allen BL Jr. The immature goat as an animal model for Legg-Calve-Perthes disease. J Invest Surg 1994;7:417-30.
27. Mont MA, Carbone JJ, Fairbank AC. Core decompression versus nonoperative management for osteonecrosis of the hip. Clin Orthop 1996;324:169-78.
28. Rosenwasser MP, Garino JP, Kiernan HA, Michelsen CB. Long term follow up of thorough debridement and cancellous bone grafting of the femoral head for avascular necrosis. Clin Orthop 1994;306:17-27.
29. Partridge KA, Oreffo RO. Gene delivery in bone tissue engineering: progress and prospects using viral and nonviral strategies. Tissue Eng 2004;10:295-307.
30. Service RF. Tissue engineers build new bone. Science 2000;289:1498-500.